Rogoziński Paweł, Bruliński Krzysztof, Malinowski Eugeniusz, Wandzel Piotr, Kucharzewski Marek
Oddział Chirurgii Klatki Piersiowej, Centrum Pulmonologii i Torakochirurgii w Bystrej.
Pneumonol Alergol Pol. 2013;81(1):68-72.
Nodular lymphoid hyperplasia (NLH) belongs to a very rare, mild, lymphoproliferative disease of unestablished aetiology historically included in the group of pseudolymphomas. Its existence was controversial for many years, until modern techniques of pathomorphological diagnosis approved it as a separate entity of lung disease. It manifests in the form of well limited nodules localized in the lungs, which are mostly identified accidentally. Clinical symptoms are rare and nonspecific; the disease usually occupies only one lung. Pathomorphological diagnosis requires immunohistochemical designation of expressions of numerous antigens in order to exclude malignant lymphoma of the lungs. Surgical resection is used in cases of larger nodules; the smaller ones require periodic observation, and the prognosis is good. The authors describe the case of 65-year-old woman with pulmonary nodules which were detected accidentally in the right lung. The patient was qualified for right-sided videothoracoscopy and removal of the lung nodule. In classic HE staining of the histological material, the presence of lymphoid infiltration of the lungs was revealed, which formed lymph follicles with reactive germinal centres. In order to differentiate from the malignant lymphatic expansion, immunohistochemical designations were made, which showed positive expression of CD20 antigen in the B cell zone, positive expression of the CD3 antigen in the T cells zone, positive expression of CD23 antigen in the lymph follicles, negative expression of bcl-2 in the lymph follicles, and positive expression of MIB-1 in the germinal centres of lymph follicles. Such a histopathological and immunohistochemical picture provided the basis for diagnosis of nodular lymphoid hyperplasia of the lung.
结节性淋巴组织增生(NLH)属于一种非常罕见的、轻度的、病因未明的淋巴组织增生性疾病,历史上曾被归入假淋巴瘤类别。多年来其存在一直存在争议,直到现代病理形态学诊断技术将其确认为一种独立的肺部疾病实体。它表现为肺部局限性良好的结节,大多是偶然发现的。临床症状罕见且无特异性;该疾病通常仅累及一侧肺。病理形态学诊断需要对多种抗原的表达进行免疫组化标记,以排除肺部恶性淋巴瘤。较大结节的病例采用手术切除;较小的结节则需要定期观察,预后良好。作者描述了一名65岁女性的病例,其右肺偶然发现有肺结节。该患者符合右侧电视胸腔镜检查及肺结节切除术的条件。在组织学材料的经典苏木精-伊红(HE)染色中,发现存在肺部淋巴样浸润,形成了具有反应性生发中心的淋巴滤泡。为了与恶性淋巴组织增生相鉴别,进行了免疫组化标记,结果显示B细胞区CD20抗原呈阳性表达,T细胞区CD3抗原呈阳性表达,淋巴滤泡中CD23抗原呈阳性表达,淋巴滤泡中bcl-2呈阴性表达,淋巴滤泡生发中心MIB-1呈阳性表达。这样的组织病理学和免疫组化表现为肺结节性淋巴组织增生的诊断提供了依据。